Literature DB >> 17855361

Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.

Ying Huang1, Jihui Qiu, Shuo Dong, Michele S Redell, Valeria Poli, Michael A Mancini, David J Tweardy.   

Abstract

Two isoforms of Stat3 (signal transducer and activator of transcription 3) are expressed in cells, alpha (p92) and beta (p83), both derived from a single gene by alternative mRNA splicing. The 55-residue C-terminal transactivation domain of Stat3alpha is deleted in Stat3beta and replaced by seven unique C-terminal residues (CT7) whose function remains uncertain. We subcloned the open reading frames of Stat3alpha and Stat3beta into the C terminus of green fluorescent protein (GFP). Fluorescent microscopic analysis of HEK293T cells transiently transfected with GFP-Stat3alpha or GFP-Stat3beta revealed similar kinetics and cytokine concentration dependence of nuclear accumulation; these findings were confirmed by high throughput microscope analysis of murine embryonic fibroblasts that lacked endogenous Stat3 but stably expressed either GFP-Stat3alpha or GFP-Stat3beta. However, although time to half-maximal cytoplasmic reaccumulation after cytokine withdrawal was 15 min for GFP-Stat3alpha, it was >180 min for GFP-Stat3beta. Furthermore, although the intranuclear mobility of GFP-Stat3alpha was rapid and increased with cytokine stimulation, the intranuclear mobility of GFP-Stat3beta in unstimulated cells was slower than that of GFP-Stat3alpha in unstimulated cells and was slowed further following cytokine stimulation. Deletion of the unique CT7 domain from Stat3beta eliminated prolonged nuclear retention but did not alter its intranuclear mobility. Thus, Stat3alpha and Stat3beta have distinct intracellular dynamics, with Stat3beta exhibiting prolonged nuclear retention and reduced intranuclear mobility especially following ligand stimulation. Prolonged nuclear retention, but not reduced intranuclear mobility, mapped to the CT7 domain of Stat3beta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855361     DOI: 10.1074/jbc.M704548200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.

Authors:  Adetola Shodeinde; Kalyani Ginjupalli; H Dan Lewis; Sheraz Riaz; Beverly E Barton
Journal:  J Mol Biochem       Date:  2013-02-20

2.  The myImageAnalysis project: a web-based application for high-content screening.

Authors:  Adam T Szafran; Michael A Mancini
Journal:  Assay Drug Dev Technol       Date:  2014 Jan-Feb       Impact factor: 1.738

3.  Antitumorigenic potential of STAT3 alternative splicing modulation.

Authors:  Francesca Zammarchi; Elisa de Stanchina; Eirini Bournazou; Teerawit Supakorndej; Kathryn Martires; Elyn Riedel; Adriana D Corben; Jacqueline F Bromberg; Luca Cartegni
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 4.  Targeting signal transducer and activator of transcription signaling pathway in leukemias.

Authors:  Mustafa Benekli; Heinz Baumann; Meir Wetzler
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

Review 5.  Regulation and function of signal transducer and activator of transcription 3.

Authors:  Qian-Rong Qi; Zeng-Ming Yang
Journal:  World J Biol Chem       Date:  2014-05-26

6.  A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Geetha Rao; Tanwir Habib; Danielle T Avery; Alain Lefèvre-Utile; Marie-Olivia Chandesris; Aziz Belkadi; Maya Chrabieh; Hanan Alwaseem; Virginie Grandin; Françoise Sarrot-Reynauld; Agathe Sénéchal; Olivier Lortholary; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Capucine Picard; Anne Puel; Vivien Béziat; Qian Zhang; Laurent Abel; Henrik Molina; Nico Marr; Stuart G Tangye; Jean-Laurent Casanova; Bertrand Boisson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

7.  STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.

Authors:  Omar Nunez Lopez; Fredrick J Bohanon; Xiaofu Wang; Na Ye; Tiziana Corsello; Yesenia Rojas-Khalil; Haijun Chen; Haiying Chen; Jia Zhou; Ravi S Radhakrishnan
Journal:  RSC Adv       Date:  2016-10-14       Impact factor: 3.361

8.  Prevention of trauma and hemorrhagic shock-mediated liver apoptosis by activation of stat3alpha.

Authors:  Ana Moran; Ayse Akcan Arikan; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Valeria Poli; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2008-06-15

Review 9.  Mitochondrial STAT3 and reactive oxygen species: A fulcrum of adipogenesis?

Authors:  Adam H Kramer; Rose Kadye; Pascalene S Houseman; Earl Prinsloo
Journal:  JAKSTAT       Date:  2015-09-11

10.  Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer.

Authors:  Katherine M Lewis; Uddalak Bharadwaj; T Kris Eckols; Mikhail Kolosov; Moses M Kasembeli; Colleen Fridley; Ricardo Siller; David J Tweardy
Journal:  Lung Cancer       Date:  2015-09-15       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.